Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 6—June 2026

Synopsis

Group A Streptococcus Disease Outbreak Associated with Large Congregate Shelter, Chicago, Illinois, USA, October 2023–January 2024

Karrie-Ann Toews1, Lauren Tietje, Anne Meyers, Marco Ciaccio, Stephanie Gretsch, Alyse Kittner, Kendall Anderson, Matthew Bertagna, Elizabeth S. Davis, Stockton Mayer, Rebecca M. Singer, Margaret Mary Butler, Diana Arce-Garza, Thomas D. Huggett, Ryan Fabrizius, Jennifer Levy, Stephanie Black, Sopio Chochua, Christopher J. Gregory, and Michelle Funk1Comments to Author 
Author affiliation: Chicago Department of Public Health, Chicago, Illinois, USA (K.-A. Toews, L. Tietje, A. Meyers, M. Ciaccio, S. Gretsch, A. Kittner, K. Anderson, M. Bertagna, J. Levy, S. Black, M. Funk); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (K.-A. Toews, S. Chochua, C.J. Gregory); Rush University Medical Center, Chicago (E.S. Davis, M.M. Butler); University of Illinois Chicago, Chicago (S. Mayer, R.M. Singer, D. Arce-Garza); Lawndale Christian Health Center, Chicago (T.D. Huggett, R. Fabrizius)

Main Article

Table

Characteristics of 426 persons screened for group A Streptococcus during point prevalence survey screening in large congregate shelter, Chicago, Illinois, USA, November 20, 2023–January 3, 2024*

Characteristic Identified through RADT, no. (%) Identified through culture, no. (%) Negative, no. (%)
Total
114 (100)
52 (100)
260 (100)
Resident
114 (100)
51 (98.1)
258 (99.2)
Staff
0 (0)
1 (1.9)
2 (0.8)
Sex
M 54 (47.4) 21 (40.4) 108 (41.5)
F 60 (52.6) 30 (57.7) 152 (58.5)
Not reported
0
1 (1.9)
0
Age group, y
0–17 61 (53.5) 32 (61.5) 135 (51.9)
18–29 27 (23.7) 14 (26.9) 57 (21.9)
30–39 22 (19.3) 6 (11.5) 52 (20.0)
40–49 4 (3.5) 0 13 (5.0)
50–59 0 0 2 (0.8)
≥60 0 0 1 (0.4)
Unknown
0
0
0
Room
A 42 (36.8) 21 (40.4) 87 (33.5)
B 31 (27.2) 14 (26.9) 81 (31.2)
C 3 (2.6) 3 (5.8) 6 (2.3)
D 10 (8.8) 5 (9.6) 26 (10.0)
E 13 (11.4) 3 (5.8) 25 (9.6)
F 5 (4.4) 0 7 (2.7)
G 2 (1.8) 0 7 (2.7)
H 1 (0.9) 3 (5.8) 1 (0.4)
Unknown or unverified 7 (6.1) 1 (1.9) 18 (6.9)
NA
0
2 (3.8)
2 (0.8)
Symptoms
Fever 76 (66.7) 29 (55.8) 162 (62.3)
Sore throat 102 (89.5) 43 (82.7) 212 (81.5)
Headache 72 (63.2) 26 (50.0) 146 (56.2)
Nausea 29 (25.4) 17 (32.7) 93 (35.8)
Vomiting 21 (18.4) 11 (21.2) 55 (21.2)
Abdominal pain 25 (21.9) 17 (32.7) 71 (27.3)
Difficulty breathing
35 (30.7)
21 (40.4)
108 (41.5)
Antibiotics prescribed 112 (98.2) 32 (61.5) 73 (28.1)

*Two cases had indeterminate results and are not included in this table. NA, not available, RADT, rapid antigen detection test.

Main Article

1These authors contributed equally to this article.

Page created: April 20, 2026
Page updated: May 15, 2026
Page reviewed: May 15, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external